XML 59 R31.htm IDEA: XBRL DOCUMENT v3.19.3
Organization and Summary of Significant Accounting Policies - Additional Information (Detail)
1 Months Ended 9 Months Ended
May 23, 2019
Position
Aug. 31, 2019
USD ($)
Feb. 28, 2018
USD ($)
Sep. 30, 2019
USD ($)
Segment
Jan. 01, 2019
USD ($)
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Number of positions reduced in global workforce | Position 80        
Percentage of reduction in global workforce 36.00%        
Restructuring completion date       Dec. 31, 2019  
Number of operating segment | Segment       1  
Cash, cash equivalents and marketable securities       $ 174,900,000  
Principal amount including interest paid in kind     $ 179,100,000 $ 179,100,000  
Debt maturity date     Dec. 31, 2023 Dec. 31, 2023  
Proceeds from offering   $ 65,600,000      
Right-of-use asset       $ 29,723,000  
Operating lease, liability       40,022,000  
Inventory reserve       $ 0  
ASC 842          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Right-of-use asset         $ 34,800,000
Operating lease, liability         $ 37,100,000
Maximum          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Expected period of payment to be received       1 year  
HEPLISAV-B?          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Minimum age approved for vaccine prevention of infection caused       18 years